This inventor holds 1 USPTO granted patent. Top assignee: Laboratorios Dalmer Sa. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: Mirian Cora Medina: Innovator in Fatty Acid Mixtures
Introduction
Mirian Cora Medina is a notable inventor based in Habana, Cuba. She has made significant contributions to the field of pharmaceutical formulations through her innovative work with fatty acids derived from sugar cane wax. Her research focuses on the development of natural mixtures that possess unique pharmacological properties.
Latest Patents
Mirian holds a patent for her invention titled "Mixture of primary fatty acids obtained from sugar cane wax." This patent describes a new natural mixture of primary fatty acids with high molecular weights, specifically those ranging from 24 to 38 carbon atoms. The mixture is particularly effective due to its reproducible composition and its extraction from sugar cane wax. The fatty acids in this mixture have been shown to have specific pharmacological properties, making them suitable for use in pharmaceutical formulations aimed at treating conditions such as hypercholesterolemia, as well as providing antiplatelet, anti-thrombotic, and anti-ischemic benefits. Additionally, this mixture has demonstrated effectiveness in inhibiting the development of gastric ulcers induced by various agents.
Career Highlights
Mirian Cora Medina is associated with Laboratorios Dalmer S.A., where she continues to advance her research and development efforts. Her work has positioned her as a key figure in the innovation of natural pharmaceutical ingredients.
Collaborations
Some of her notable coworkers include Luis Gonzáles Bravo and David Marrero Delange, who have contributed to her research endeavors.
Conclusion
Mirian Cora Medina's innovative work in the field of fatty acids has the potential to significantly impact pharmaceutical formulations and improve health outcomes. Her contributions exemplify the importance of research and innovation in developing effective treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile